Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Fabio D'AMORE"'
Autor:
Sara Di Giusto, Eleonora Toffoletti, Massimiliano Bonifacio, Gianni Binotto, Maria Cristina Miggiano, Elisabetta Calistri, Manuela Stulle, Anna Ermacora, Rossella Stella, Luigi Scaffidi, Fabio D'Amore, Giorgia Scotton, Davide Griguolo, Giovanna De Matteis, Roberta Bertorelle, Mauro Krampera, Gianpietro Semenzato, Renato Fanin, Daniela Damiani, Mario Tiribelli
Publikováno v:
Cancer Medicine, Vol 12, Iss 3, Pp 3180-3184 (2023)
Abstract We analyzed BCR::ABL1 expression at stop and in the first month after discontinuation in 168 chronic myeloid leukemia patients who stopped imatinib or 2nd generation tyrosine kinase inhibitors (2G‐TKIs) while in sustained deep molecular re
Externí odkaz:
https://doaj.org/article/6d9378c7422342778ca471ef994a2735
Autor:
Simone Zoletto, Marco Pizzi, De Crescenzo Andrea, Fabio D’amore, Alberto Friziero, Irene Bertozzi, Giuseppe Carli, Barbara Famengo, Ilaria Nichele, Nicola Vianelli, Giuseppe Auteri, Elena Sabattini, Angelo Paolo Dei Tos, Livio Trentin, Fabrizio Vianello
Publikováno v:
HemaSphere, Vol 7, p e05638b6 (2023)
Externí odkaz:
https://doaj.org/article/813d515e71f243f1bf45dfacdd55d78c
Autor:
Francesco Angotzi, Marco Petrella, Tamara Berno, Gianni Binotto, Giorgia Bonetto, Antonio Branca, Marco Carraro, Chiara Adele Cavaretta, Alessandro Cellini, Fabio D’Amore, Laura Forlani, Ilaria Gianesello, Carmela Gurrieri, Silvia Imbergamo, Federica Lessi, Antonio Maroccia, Federica Mazzetto, Laura Pavan, Sara Pezone, Francesco Piazza, Stefano Pravato, Valeria Ruocco, Greta Scapinello, Fabrizio Vianello, Renato Zambello, Ivan Zatta, Simone Zoletto, Andrea Padoan, Livio Trentin, Andrea Visentin
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
The approved combination of Tixagevimab/Cilgavimab has been shown to decrease the rate of symptomatic SARS-CoV-2 infection in patients at increased risk of inadequate response to vaccination. However, Tixagevimab/Cilgavimab was tested in a few studie
Externí odkaz:
https://doaj.org/article/1d24015006414524bad71f3a10a0bffd
Autor:
Felice V Vitale, Valentina Giaimo, Alessandro D’Angelo, Alessia Dottore, Fabio D’Amore, Paolo Colina, Mario Raffaele
Publikováno v:
SAGE Open Medical Case Reports, Vol 11 (2023)
Occurrence of venous thromboembolism in cancer patients (patients) undergoing chemotherapy is a remarkable concern for the oncologist. In addition, careful attention has to be paid to the possible major bleeding when patients carrying gastrointestina
Externí odkaz:
https://doaj.org/article/97fa97c18c484586a53fa6e2c71b32a4
Autor:
Dario Raimondo, Fabio Romeo, Ilaria Tarantino, Rita Alloro, Giuseppe Conoscenti, Fabio D’Amore, Emanuele Sinagra, Marcello Maida, E. Borina, Socrate Pallio, Alessio Santagati, Francesca Rossi, Roberta Bellerone
Publikováno v:
Minerva Gastroenterology. 69
Background In clinical practice, standard endoscopic treatment of biliary stones fails in up to 10% of patients, and more invasive procedures such as percutaneous trans-hepatic interventions or surgery might become necessary. The aim of this multi-ce
Autor:
Marco Pizzi, Fabrizio Vianello, Gianni Binotto, Nicola Vianelli, Giuseppe Carli, Giuseppe Auteri, Ilaria Nichele, Marta Sbaraglia, Simone Zoletto, Federico Scarmozzino, Rita Bresciani, Fabio d'Amore, Alberto Friziero, Vincenza Guzzardo, Irene Bertozzi, Barbara Famengo, Emanuele S. G. d'Amore, Elena Sabattini, Angelo Paolo Dei Tos
Publikováno v:
British journal of haematologyREFERENCES. 198(5)
Thrombopoietin receptor agonists (TPO-RA) are a valid therapy for immune thrombocytopenia (ITP), due to megakaryocyte stimulation and (poorly characterised) immune-modulatory effects. The spleen is pivotal in the pathogenesis of ITP, yet little is kn
Autor:
Socrate PALLIO, Emanuele SINAGRA, Alessio SANTAGATI, Fabio D’AMORE, Giancarlo POMPEI, Giuseppe CONOSCENTI, Fabio ROMEO, Eleonora BORINA, Giuseppinella MELITA, Francesca ROSSI, Marcello MAIDA, Rita ALLORO, Ilaria TARANTINO, Dario RAIMONDO
Publikováno v:
Minerva gastroenterology.
Direct bile ducts visualization through cholangioscopy has gained popularity due to its better diagnostic accuracy than a standard ERCP in indeterminate biliary stricture.We aimed to review our catheter-based cholangioscopy interventions in patients
Autor:
Sara Di Giusto, Eleonora Toffoletti, Massimiliano Bonifacio, Gianni Binotto, Maria Cristina Miggiano, Elisabetta Calistri, Manuela Stulle, Anna Ermacora, Rossella Stella, Luigi Scaffidi, Fabio D'Amore, Giorgia Scotton, Davide Griguolo, Giovanna De Matteis, Roberta Bertorelle, Mauro Krampera, Gianpietro Semenzato, Renato Fanin, Daniela Damiani, Mario Tiribelli
We analyzed BCR::ABL1 expression at stop and in the first month after discontinuation in 168 chronic myeloid leukemia patients who stopped imatinib or 2nd generation tyrosine kinase inhibitors (2G-TKIs) while in sustained deep molecular response. Pat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f612b6db58b703a2fc6d6d69bce3536d
https://hdl.handle.net/11390/1235784
https://hdl.handle.net/11390/1235784
Autor:
Marta Sbaraglia, Elena Sabattini, Fabrizio Fabris, Alberto Friziero, Fabio D'Amore, Cosimo Sperti, Matteo Fassan, Lucia Moletta, Andrea Grego, Fabrizio Vianello, Angelo Paolo Dei Tos, Marco Pizzi, Simone Zoletto, Irene Bertozzi, Gianni Binotto, Elisa Carraro, Gianfranco Da Dalt, Giovanni Capovilla, Simona Righi, Stefano Merigliano, Elisa Sefora Pierobon, Nicola Baldan
Publikováno v:
European journal of haematologyREFERENCES. 106(2)
Objective Immune thrombocytopenia (ITP) is an acquired disorder, characterized by immune-mediated platelet destruction. The spleen plays a key pathogenic role in ITP and splenectomy is a valuable second-line therapy for this disease. Little is known
Autor:
Elena Maria Elli, Florian H. Heidel, Uros Markovic, Fabrizio Pane, Gianpietro Semenzato, Daniela Bartoletti, Francesca Palandri, Giulia Benevolo, Mauro Krampera, Malgorzata Monika Trawinska, Micaela Bergamaschi, Mario Tiribelli, Giovanni Caocci, Lucia Catani, Elisabetta Abruzzese, Massimo Breccia, Rossella Stella, Antonio Cuneo, Fabio D'Amore, Alessandro Isidori, Costanza Bosi, Monica Crugnola, Lisa Gandolfi, Domenico Russo, Alessandra Iurlo, Nicola Polverelli, Roberto M. Lemoli, Michele Cavo, Gianni Binotto, Roberto Latagliata, Francesco Cavazzini, Bruno Martino, Daniele Cattaneo, Nicola Vianelli, Novella Pugliese, Luigi Scaffidi, Massimiliano Bonifacio, Mariella D'Adda, Alessia Tieghi, Giuseppe Auteri, Giuseppe A. Palumbo
Ruxolitinib (RUX), the first JAK1/JAK2 inhibitor approved for myelofibrosis (MF) therapy, has recently been associated with the occurrence of second primary malignancies (SPMs), mainly lymphomas and non-melanoma skin cancers (NMSCs). We analyzed the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8d8abbcaca804c8d9620fa8227a1112f
http://hdl.handle.net/11562/1033116
http://hdl.handle.net/11562/1033116